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Abstract 
 
 
Salivary gland hypofunction is a major disorder of salivary glands, and can arise 
either from diseases such as xerostomia, or from defective epithelial morphogenesis 
during embryogenesis. Hundreds of thousands of individuals suffer from dry mouth, and 
there is currently no restorative therapy for these patients. Investigation of salivary gland 
developmental biology will inform regenerative therapies. Currently it is known that 
retinoic acid (RA), the biologically active form of Vitamin A, is required for proper 
development of the salivary gland, but little is known about its cellular mechanism 
regulating organogenesis. This study sought to analyze salivary gland development in 
Rdh10 knock down mice to determine if vascular development is impaired, to quantify 
expression of candidate genes known to be both targets of RA signaling and be involved 
in angiogenesis, and then identify novel angiogenic genes. We show that retinoic acid 
signaling alters expression of genes involved in angiogenesis in Rdh10 knockdowns. 
Using RNAscope, immunocytochemistry, and qPCR, we characterize the expression and 
location of Ctgf and its protein product, a gene known to aid blood vessel formation. This 
is the first study to characterize a vascular phenotype associated with Rdh10 mutants, and 
identify angiogenic gene targets of RA signaling in Rdh10 mutants.  
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INTRODUCTION 
Salivary glands are essential for oral health, and loss of their function results in 
xerostomia, dysphagia, malnutrition, oral mucositis, oral discomfort, and increased oral 
infections (Cady, 2007; Hancock, Epstein, & Sadler, 2003; Nguyen et al., 2007). Head 
and neck cancer treatment causes significant damage to salivary gland functioning, and 
each year 50,000 new cases of this cancer are diagnosed in the United States, while 
globally it ranks as the 5th most common malignancy (Seiwert, Salama, & Vokes, 2007). 
Certain autoimmune diseases also impair saliva secretion, such as Sjogren’s syndrome, 
which is estimated to impact greater than 0.4% of the global population (Patel & 
Shahane, 2014). Therefore, there is a need to develop therapies, which requires 
knowledge about salivary gland biology. Currently, researchers attempting to design 
therapies are investigating two possible approaches for remedying loss of salivary gland 
tissue and functioning: regenerating existing viable tissue, and initiating salivary gland 
growth from non-salivary gland tissue (Lombaert, Isabelle et al., 2016). Studying how a 
submandibular salivary gland (SMG) grows and branches within a mouse embryo 
informs methods to design therapies seeking to achieve salivary gland repair by either of 
these approaches. 
Embryonic murine SMG development initiates on embryonic day 11.5 (E11.5) when 
thickening occurs of buccal epithelium on either side of the developing tongue (Tucker, 
2007). By E12.5, this epithelium has extended into a surrounding mesenchyme to form a 
preliminary bud before undergoing branching morphogenesis, canalization, and cell 
differentiation. Angiogenesis occurs concurrently (Fig. 1), and the developing vasculature 
directs epithelial patterning and differentiation (Kwon, Nelson, DeSantis, Morrissey, & 
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Larsen, 2017). Beyond the vasculature’s standard function of providing nutrients to the 
organ, for developing salivary glands it has been shown to define the branching structure 
and organization during morphogenesis. This vasculature can be visualized in the 
developing embryo by immunostaining for endothelial cells, which are positive for the 
marker Cluster Differentiation 31 (CD31).
 
Figure 1. Diagram highlighting how the vasculature develops concurrently with 
epithelium and participates in defining an embryonic mouse salivary gland’s 
morphology. 
Salivary gland patterning and morphogenesis are regulated by retinoic acid (RA) 
(Wright et al., 2015), which is the biologically active form of retinol, commonly known 
as Vitamin A (Niederreither & Dolle, 2008). Retinol is typically absorbed through an 
organism’s diet, and is then metabolized to RA in two reactions, the first of which is 
mediated by retinol dehydrogenase 10 (RDH10) (Sandell, Lynn, Inman, McDowell, & 
Trainor, 2012; Sandell et al., 2007). Once formed, RA acts as a ligand by binding to 
specific nuclear transcription factors called retinoic acid receptors located both in the 
cytosol and at target DNA elements; this complex dimerizes with the Retinoid X 
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Receptor (RXR) and activates transcription of developmental genes (Metzler & Sandell, 
2016) (Fig. 2). 
 
Figure 2. Diagram detailing the metabolic transformation of Vitamin A (all-trans-
Retinol) to Retinoic Acid and this molecule’s transcriptional activity.  
 Rdh10 mutant mice, which have deficient RA production, have defective SMG 
morphogenesis (Wright et al, 2015). The canonical RA signaling transpires in several 
associated embryonic salivary gland tissues, including epithelium, accompanying 
parasympathetic ganglion neurons, and non-neuronal mesenchyme (Abashev, Metzler, 
Wright, & Sandell, 2017), but it is not currently known if it occurs in vascular tissue. 
While loss of RA signaling leads to defective salivary gland branching, the mechanism 
for this malformation is not fully understood. However, given the known role for RA in 
regulating gene transcription, it is likely that the Rdh10-/- mutant salivary gland 
phenotype (Fig. 3) arises from altered gene expression.   
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Figure 3.  Drawing representing the epithelial-branching defects shown in a murine 
mutant salivary gland whose gene encoding Rdh10 has been conditionally knocked out. 
Unpublished data from the Sandell Lab show multiple genes are downregulated in a 
cultured salivary gland whose RA signaling was blocked by BMS493 (Griebel & Sandell, 
unpublished), a pharmacological pan-RAR inhibitor (Klein et al., 1996). Many of the 
these gene targets of RA signaling are involved in angiogenesis. One such gene, Ctgf, 
encodes Connective Tissue Growth Factor, a protein that stimulates the production of 
endothelial basement membrane components such as collagen IV, allowing for adhesion 
of pericytes to associated endothelial cells (Ponticos, 2013). Due to these factors, Ctgf has 
been shown to be essential for vascular development by regulating endothelial-perictye 
interactions (Hall-Glenn, 2012). Additionally, Ctgf is necessary for lung capillary 
formation and branching morphogenesis (Wu S, Platteau A, Chen S, McNamara G, 
Whitsett J, Bancalari E, 2010). For thess reasons, Ctgf was chosen as the principal 
candidate gene for exploration into the potential relationship between RA and 
angiogensis.  
Preliminary experiments for the current study established there is a vascular 
phenotype associated with Rdh10 mutants. Seeking to establish a mechanistic connection 
between lack of RA signaling and a predicted vascular phenotype, this study then 
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attempts to characterize the principal candidate gene Ctgf by quantifying its expression in 
Rdh10 knockouts in vivo and localizing its mRNA transcript and gene product within a 
developing salivary gland. Furthermore, the additional candidate genes identified in the 
cultured inhibition of RA signaling will be analyzed for changes in gene expression 
within an Rdh10 mutant. Lastly, this study examines expression rates in Rdh10 mutants 
of all genes known to be involved in angiogenesis of a developing salivary gland in order 
to identify genes requiring transcriptional activation by RA signaling to facilitate 
angiogenesis. This study also validated the altered retinoid homeostasis in salivary glands 
of Rdh10 mutant embryos by examining expression levels in Rdh10 mutants of genes 
involved in the metabolism of Vitamin A. 
This study has the potential to expand the knowledge regarding the mechanism by 
which Vitamin A regulates salivary gland development. Because developing vasculature 
has been shown to direct the morphology of budding epithelium in a salivary gland, it is 
possible that reduced expression of genes critical to angiogenesis due to loss of RA 
signaling could give rise to the defective phenotype observed in Vitamin A deficient 
mice. Knowledge of proteins encoded by genes such as Ctgf with altered expression in 
Rdh10 knockdowns could provide a mechanistic link between Vitamin A and impaired 
endothelial branching morphogenesis. Additionally, gene expression levels reported by in 
vivo qPCR analysis of angiogenic candidate genes in Rdh10 knockouts in this study can 
be compared with those conducted in vitro to further understand how these genes are 
regulated. Lastly, the results from qPCR and DNA array analysis can inform future 
experiments regarding what genes to investigate to further explore Vitamin A’s role in 
murine SMG organogenesis.   
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HYPOTHESIS 
 Rdh10 conditional mutant submandibular glands will have disrupted 
vasculogenesis compared to controls and this will correlate with the misexpression of 
genes, such as Ctgf, known to play a role in blood vessel development. 
  
 12   
METHODS 
Animals. The generation of the mutant (Rdh10delta) and conditional (Rdh10flox) alleles has 
been described previously (Sandell et al., 2012). In order to knock out the conditional 
Rdh10 allele by recombination, this study also included mice carrying the cre-ERT2 allele 
(Ventura et. al., 2007). To generate litters containing both Rdh10 conditional mutant and 
Rdh10 heterozygote control embryos, Rdh10delta/+ mice were set up in a timed mating 
with Rdh10flox/flox;ERT2*2 mice. Day of vaginal plug was considered E0.5. We have 
previously shown that these litters contain ~50:50 Rdh10delta/flox;ERT2 (conditional 
mutant) and Rdh10flox/+;ERT2 (heterozygote control) embryos (Metzler et. al., 2018).  
To knock out the conditional Rdh10 allele in embryos, pregnant dams were administered 
5mg Tamoxifen + 2mg Progesterone in 250µl corn oil by oral gavage on day E8.5 as 
described in Metzler et al. (2018). All mice were maintained at the University of 
Louisville, and all experiments using mice were preformed according to a protocol 
approved by the Institutional Animal Care and Use Committee at the University of 
Louisville. 
 
Acquisition of cDNA and Quantitative Polymerase Chain Reaction. SMGs were dissected 
from embryonic mice at E13.5. RNA from their SMG was then extracted and isolated 
using RNeasy Micro Kit (Qiagen). This RNA was then converted to cDNA via a reverse 
transcriptase from Super Script III (Invitrogen). The resulting cDNA underwent a 
polymerase chain reaction to quantify the gene expression of vasculature genes such as 
CD31 using Angiogenesis RT2 Profiler PCR Array (Qiagen).  
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RNAscope. In situ hybridization assay from Advanced Cell Diagnostics was used to 
visualize the location of the target RNA within developing SMGs. SMG samples were 
harvested at E13.5, sectioned, and then paraffinized. After the slides had baked for an 
hour at 60C, they were deparaffinized to allow for target retrieval using a Tissue Tek jar 
containing Target Retrieval solution in a steamer. The slides were then left in a 
humidifying box overnight. After a series of prepping reagents, the probe Mm-CTGF-C2 
was added to each slide. Next, AMP1, AMP2, and AMP3 were added between 30 minute 
incubations in the HybEZ oven. The fluorophore solutions were then added: HRP-C1, 
Opal 520, and HRP-blocker, followed by DAPI. The slides were sealed using Prolong 
Gold and coverslip. 
 
Immunocytochemistry. SMG explants underwent whole mount immunostaining as carried 
out by the Sandell lab in 2017 using identical protocol (Abashev et al., 2017). The 
primary antibody used was the anti-CD31 antibody ab28364 (Abcam), while the 
secondary will be Alexa Fluor 546 Goat Anti-Rabbit IgG (H+L) A-11010 (Invitrogen). 
Images were viewed using a Zeiss AX10 confocal microscope.  
 
Wholemount staining of vasculature. Whole SMGs were dissected from E13.5 embryos 
and fixed in 10% NBF. Immunostaining wholemount was performed as previously 
described (Abashev et. al., 2017). Primary antibodies used were anti-CD31 (abcam 
ab28364, 1:50) and anti-TUBB3 (BioLegend MMS-435P, 1:1000).  Secondary antibodies 
used were Alexa Fluor 546 (ThermoFisher A-11003, 1:300) and Alexa Fluor 660 
(ThermoFisher A-21054, 1:300).  
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Wholemount imaging. Imaging was performed on a Leica SP8 confocal microscope with 
solid state lasers 405, 488, 552, and 638nm. Z-stacks were rendered into image 
projections using the software Imaris. 
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RESULTS 
 
Vascular Phenotype Associated with Rdh10 Mutants 
Embryonic salivary glands of Rdh10 mutants produce endothelial tissue, but cannot 
form continuous blood vessels 
 To determine whether RA signaling is required for angiogenesis in a murine 
salivary gland, cluster of differentiation 31 (CD31; PECAM1 – Mouse Genome 
Informatics)+ vasculature was examined on E13.5 Rdh10 knockdown salivary glands. 
SMG explants dissected and paraffinized on E13.5 underwent whole mount 
immunostaining using the anti-CD31 antibody ab28364 (Abcam).  The following six 
images are each from separate animals. On left, the animals are capable of metabolizing 
Vitamin A, while those animals shown on right cannot. This accounts for the difference 
in epithelial branching shown in all samples between the controls and mutants. Defective 
branching is a known phenotype in Rdh10-/- conditional mutants. These images show that 
endothelial cells (shown in red fluorescence) are present in mutants; however, observing 
blood vessel morphology is difficult in 2D sections. 
 
 
 
 
 
 
 
 16   
Cross-sectional comparison of vasculature in control and Rdh10 mutant mouse SMG 
 
Figure 4. Vasculature is present in developing salivary gland of Rdh10 mutants.  
Salivary glands were dissected from embryos and paraffinized on E13.5. Cross sections 
are taken in the frontal plane. Heterozygous controls (Rdh10+/-) are shown on left while 
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conditional knockdowns (Rdh10-/-) are shown right. All cells appearing blue are stained 
with DAPI, a molecule that binds to the minor groove of double stranded DNA. The neon 
green pigmentation shows cells stained with anti-E-cadherin, an antibody that binds the 
epithelial tissue within the salivary gland. The red and yellow pigmentation shows cells 
stained with Cluster of Differentiation 31 (CD31), otherwise known as Platelet 
Endothelial Cell Adhesion Molecule (PECAM), which binds endothelial cells and serves 
as a marker for angiogenesis. Autofluorescence naturally emitted from biological 
structures was imaged in dark green. Images were viewed through a Zeiss AX10 
fluorescent microscope, and represent merges of separate images taken at different 
wavelengths to capture the fluorescence of each secondary antibody. The merged image 
changes the autofluorescence to a desaturated gray color which aids in distinguishing true 
signals from naturally occurring ones.  
 
Because the previous image (Fig. 4) analyzed the glands only in cross-section, the 
3D structure of the vasculature of an Rdh10 mutant salivary gland remained unknown. In 
order to visualize the multi-dimensional organization of SMG endothelial tissue, 
wholemount staining with CD31 was conducted on E13.5 SMG explants. Wholemount 
immunostaining was performed as previously described (Abashev et. al., 2017). Primary 
antibodies used were anti-CD31 (abcam ab28364, 1:50) and anti-TUBB3 (BioLegend 
MMS-435P, 1:1000). The following images show that vasculature is underdeveloped in 
SMG explants of Rdh10  knockdown mice. In mutant glands, endothelial cells are still 
present, but are unable to form elongated blood vessels.  
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Wholemount comparison of vasculature in control and mutant mouse SMG 
 
Figure 5.  Rdh10 mutants cannot form continuous blood vessels. SMG at E13.5 of 
heterozygous controls (Rdh10+/-) are shown on left while conditional knockdowns (Rdh10-
/-) are shown on right. Whole SMGs were dissected from E13.5 embryos and fixed in 10% 
NBF. Immunostaining wholemount was performed as previously described (Abashev et. 
al., 2017). Imaging was performed on a Leica SP8 confocal microscope with solid state 
lasers 405, 488, 552, and 638nm. The primary antibody anti-TUBB3 binds nerve tissue, 
while anti-CD31 binds endothelial tissue. This experiment was conducted by Melissa 
Metzler, an associate researcher in Lisa Sandell’s lab at the University of Louisville School 
of Dentistry. Mutant explants show no presence of elongated vasculature. 
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Investigation of Candidate Angiogenic Genes 
Principal candidate gene Ctgf is expressed in spatially restricted domains of salivary 
glands but is unchanged in Rdh10 mutants 
The vascular phenotype discovered to be associated with Rdh10 knockdowns 
indicated that lack of RA signaling may result in dysregulation of genes critical to 
angiogenesis. Ctgf was chosen as this study’s principal candidate gene for 
characterization within a developing salivary gland because it is known to be a direct 
target of RA signaling (Delacroix et al, 2009), downregulated in RA signal inhibited 
salivary glands (Griebel & Sandell, unpublished), and necessary for lung capillary 
formation and branching morphogenesis (Wu S, Platteau A, Chen S, McNamara G, 
Whitsett J, Bancalari E, 2010).  
Previous transcriptional analyses has demonstrated that Ctgf is expressed in 
salivary glands (NIDCR, Salivary Gland Atlas), but the whole gland spatial distribution 
has not been studied. In order to define the whole gland tissue localization of Ctgf RNA 
expression in normal salivary glands, RNAscope was performed in situ hybridization on 
paraffinized frontal sections of E13.5 wild type salivary glands. Red punctate dots show 
single Ctgf mRNA molecules bound to double Z RNAscope Probes, a fluorescing 
technique that utilizes a ~20 nucleotide target-specific probe hybridized to target RNA 
molecules and is amplified by multiple label probes. Ctgf transcripts were observed to 
localize in epithelial tissue, while mesenchymal tissue appeared to have little or no Ctgf 
RNA (Fig. 6). Furthermore, transcripts are most concentrated near the base of endbuds, 
but additional samples would need to be gathered to confirm if this is representative of 
Ctgf expression in salivary glands. 
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Location of Ctgf mRNA in mouse SMG cross-section 
 
Figure 6. Ctgf mRNA localizes to epithelial tissue of SMG at E13.5. 
Frontal section of E13.5 SMG from wild type mouse embryo with Ctgf RNA labeled by 
RNAscope in situ hybridization. Red signal indicates Ctgf RNA. Blue is all nuclei labeled 
with DAPI. Epithelium is outlined by white line. Ctgf RNA is localized within epithelium, 
but is scarcely detected in the surrounding mesenchyme.  
 
Although the previous experiment defines the expression pattern of Ctgf RNA, the 
localization of the Ctgf protein within a developing salivary gland was previously 
unknown. To visualize the localization of CTGF protein in a developing salivary gland, 
immunocytochemistry was performed on wild type salivary gland sections using anti-
CTGF antibody. Dissection of normal salivary glands occurred on E13.5, and samples 
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were paraffinized, sectional frontally, and stained using anti-CD31 antibody ab28364 
(Abcam). CTGF appears to localize at the base of ducts in a pattern similar to known 
neuron innervation. No significant CTGF staining was observed in the mesenchyme or 
epithelium. 
Location of CTGF protein in mouse SMG cross-section 
 
Figure 7. CTGF protein in SMG cross-section at E13.5 
localizes near ducts in pattern reminiscent of neuronal 
structures.  Frontal section of E13.5 wild type embryo 
SMG stained with anti-CTGF antibody and imaged 
through a Zeiss AX10 fluorescent microscope. High 
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concentration of CTGF protein (denoted by yellow arrows) 
is detected at base of endbuds in region known to be 
occupied by parasympathetic nerve. Red fluorescence 
indicates presence of CTGF, while blue indicates nuclei of 
all cells stained with DAPI. Epithelium is outlined by 
white line. In this section only endbuds are visible and 
ducts are not within the plane of the section. 
 
Previous experiments identifying genes of RA signaling were conducted using the 
pharmacological inhibitor BMS (Griebel & Sandell, unpublished), but it was not known 
if gene expression would be similarly altered in salivary glands of Rdh10 mutant embryos 
in vivo. To test this, a qPCR array examining genes associated with vasculogenesis 
analyzed gene expression in Rdh10 mutants relative to controls. RNA was extracted from 
SMG of Rdh10 mutant embryos on E13.5 and converted to cDNA for qPCR analysis. 
The array analyzed cDNA samples from three heterozygous controls (Rdh10+/-) and three 
conditional knockouts (Rdh10-/-), and the average delta Ct values from each group are 
presented in the figure below. Although Ctgf has reduced expression in salivary glands 
cultured with BMS, this in vivo analysis shows that expression of Ctgf is not significantly 
altered in Rdh10 mutant salivary glands (Fig 8).  
Relative expression of Ctgf in Rdh10 mutants 
 
Figure 8. Ctgf expression is not changed in Rdh10 mutant.  
Ct. H1-3 Avg. Ct. M1-3 Avg. p.value t.statistic log2 foldchange
Ctgf 9.01 9.26 0.498 -0.74356 -0.02541
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Gene expression rates were measured using a Qiagen RT PAMM-
024ZA-6 “Mouse Angiogenesis” Profiler Array. The plate examined 
77 genes known to be involved in murine angiogenesis. Six cDNA 
samples were used in total: three heterozygous controls (Rdh10+/-) and 
three conditional knockouts (Rdh10-/-). Six RT Profiler Array plates 
were used: one for each cDNA sample. The average Ct values for the 
heterozygous controls are shown in the second column, while the 
average for the mutants is shown in the third. The P-value associated 
with the change in expression between the mutants and controls was 
0.498. The housekeeping gene used for this experiment was Gapdh.  
 
 
Additional angiogenic candidate genes are not altered in Rdh10 mutants 
Because the principal candidate gene Ctgf had no change in expression in Rdh10 
mutants, the additional candidate genes identified in previous studies (Griebel & Sandell, 
unpublished) were similarly analyzed for expression changes in Rdh10 mutants. These 
genes, which are known to facilitate angiogenesis, were grouped into two categories: 
those involved in extracellular matrix processes, and those involved in the production of 
developmental growth factors. For each gene studied, the cDNA from SMG of three 
heterozygous controls (Rdh10+/-) and three conditional knockouts (Rdh10-/-) were 
analyzed. qPCR was used to analyze the relative expression of these genes in an Rdh10 
mutant salivary gland. RNA was extracted from SMG of Rdh10 mutant embryos on 
E13.5 and converted to cDNA for qPCR analysis. Primers for these genes were designed 
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for use in qPCR, and in order to assess primer efficiencies, qPCR was performed on five-
fold serial dilutions of DNA. Primers that regressed within 90-110% of the line of best fit 
were selected for further use in quantitative assays. These analyses can be found in 
Analysis of Primer Efficiencies in the Supplemental Figures of this study. All qPCR 
analyses used primers with validated efficiencies. The expression of all candidate genes 
associated with extracellular matrix processes and developmental growth factors was 
unchanged in Rdh10 mutants (Fig. 9, Fig. 10). These data demonstrate that the vascular 
phenotype observed in Fig. 5 is not due to altered regulation of these genes. 
 
Gene expression in Rdh10 knockdowns of extracellular matrix process genes 
 
Figure 9. Expression rates of extracellular matrix genes Mmp2, Vtn, and Thbs2 are 
unchanged in SMG of Rdh10 mutants. Gene expression was measured using an 
Applied Biosystems 7500 Real-Time qPCR System. Relative expression graphs are 
constructed comparing the Ct values examined in murine cDNA of heterozygous 
controls (Rdh10+/) to conditional mutants (Rdh10-/-). These results are normalized to 
Gapdh, and represent the average between three controls and three mutants. Expression 
rates of these genes are not changed in the mutants. 
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Gene Expression in Rdh10 knockdowns of developmental growth factor genes 
 
Figure 10. Expression rates of Bmp4, Igf1, Fgf8, Bmp2, Fgf7, and Fgfr2b are 
unchanged in Rdh10 mutants. Gene expression was measured using an Applied 
Biosystems 7500 Real-Time qPCR System. Relative expression graphs are constructed 
comparing the Ct values examined in murine cDNA of heterozygous controls 
(Rdh10+/-) to conditional mutants (Rdh10-/-). These results are normalized to Gapdh, and 
represent the average between three controls and three mutants. Expression rates of these 
genes are not changed in the mutants.  
 
 
 
 
 
Five angiogenic genes discovered to be altered in Rdh10 mutants 
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Because the characterization of this study’s candidate genes indicated that none of 
them experienced altered expression in Rdh10 mutants, we sought next to identify novel 
genes that were perturbed in Rdh10 mutant SMG to gain insight as to how RA signaling 
gives rise to the vascular phenotype discovered in Rdh10 mutants. In order to examine 
the expression of all genes known to be associated with angiogenesis in a salivary gland, 
a qPCR array was used to analyze cDNA from Rdh10 mutant SMG. The following data 
were gathered using a Qiagen RT PAMM-024ZA-6 “Mouse Angiogenesis” Profiler 
Array. The plate included 77 genes known to be involved in murine angiogenesis. Six 
cDNA samples converted from RNA that was harvested from E13.5 SMGs were used in 
total: three heterozygous controls (Rdh10+/-) and three conditional knockouts (Rdh10-/-). 
Six RT Profiler Array plates were used: one for each cDNA sample. Of the 77 genes 
examined, five showed statistically significant changes in transcript abundance in 
mutants compared to controls. These genes are the following: Angpt2, Jag1, Mapk14, 
Ptgs1, and S1pr1 (Fig. 11, 12). All genes except S1pr1 were downregulated in Rdh10 
mutants, while S1pr1 was upregulated. 
 
Figure 11. Genes s1pr1, Angpt2, Jag1, Ptgs1, and Mapk14 are altered in Rdh10 
mutants. Delta Ct values of three heterozygous controls and three Rdh10 mutants are 
shown. This table is arranged in increasing P value. These data were found using the 
Qiagen RT PAMM-024ZA-6 “Mouse Angiogenesis” Profiler Array. Dissections of SMG 
Ct.B1275.H1 Ct.B1275.H2 Ct.B1299.H1 Ct.B1275.M1 Ct.B1275.M2 Ct.B1299.M1 p.value
S1pr1 5.9914 5.937 5.9711 5.474 5.454 5.3338 0.000303
Angpt2 8.5574 8.7536 8.3373 9.7673 9.5177 9.5468 0.001796
Jag1 5.6459 5.4903 5.3719 5.9745 5.7919 5.9146 0.0151
Ptgs1 9.3267 8.9818 8.6138 9.608 9.8959 9.7548 0.024707
Mapk14 5.3609 5.5119 5.4247 5.598 5.544 5.6919 0.043798
Delta CT values
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from embryos occurred on E13.5, after which RNA extraction and conversion to cDNA 
took place. Five genes, s1pr1, Angpt2, Jag1, Ptgs1, and Mapk14, are altered in Rdh10 
mutants.  
 
Relative expression of altered angiogenic genes in Rdh10 mutants 
 
Figure 12.  Angpt2, Jag1, Mapk14, and Ptgs1 are downregulated while 
S1pr1 is upregulated in Rdh10 mutants. Relative expression (measured 
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by CT) of angiogenic genes which showed a significant change in 
mutants compared to control. These data were found using the Qiagen RT 
PAMM-024ZA-6 “Mouse Angiogenesis” Profiler Array. Dissections of 
embryos occurred on E13.5, after which RNA extraction and conversion 
to cDNA took place. Four of these genes are down-regulated and one is 
up-regulated. Samples with significant p-values are shown in orange. 
These data show RA signaling is required for the proper expression of 
these five genes that are associated with vascular development.  
 
 
Three genes involved in the metabolism of Vitamin A found to have altered 
expression in Rdh10 mutants 
These genes were studied as part of a supplemental project carried out in the 
Sandell Lab, and are not associated with angiogenesis in a developing salivary gland. In 
order to assess how the salivary gland responds to a lack of RA and its signaling, these 
genes were analyzed for changes in expression rates. Dissection of embryos occurred on 
E13.5, and RNA extraction and conversion to cDNA was completed afterwards. The 
qPCR analyses of these genes included cDNA samples from three heterozygous controls 
(Rdh10+/-) and three conditional knockouts (Rdh10-/-). Three genes were found to have 
altered expression in Rdh10 mutants: Aldh1a1, Aldh1a2, and Cyp26a1 (Fig. 13).  The 
altered expression of these genes validates perturbation of RA homeostasis in SMG of 
Rdh10 mutant embryos. 
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Relative expression of Vitamin A metabolic genes in Rdh10 mutants 
 
Figure 13. Expression rates of Aldh1a1, Aldh1a2, and Cyp26a1 are altered in 
Rdh10 mutants, while those of Cyp26b1, Dhrs3, RARb, and Stra6 are unchanged.  
Gene expression was measured using an Applied Biosystems 7500 Real-Time qPCR 
System. Relative expression graphs are constructed comparing the Ct values 
examined in murine cDNA of heterozygous controls (Rdh10+/-) to conditional mutants 
(Rdh10-/-). These results are normalized to Gapdh, and represent the average between 
three controls and three mutants. Samples with significant p-values are shown in 
orange. A two-sample t-Test assuming equal variances showed a one-tailed P value for 
Aldh1a1 of 0.033, Aldh1a2 of 0.042, and Cyp26a1 of 0.036. Aldh1a1 and Cyp26a1 are 
downregulated while Aldh1a2 is upregulated in Rdh10 mutants. 
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DISCUSSION 
 This study was the first to examine the effect of blood vessel development on 
embryonic salivary glands of mouse mutants with impaired Vitamin A metabolism. 
Although Ctgf was not found to be a significant gene target of RA signaling in vivo, we 
demonstrate that salivary glands of Rdh10 knockdowns have altered expression of genes 
known to aid in angiogenesis (Fig. 11) as well as having underdeveloped blood vessels 
(Fig. 5) at E13.5. These findings support the hypothesis that Vitamin A in its biologically 
active form RA regulates proper development of a salivary gland’s vasculature through 
transcriptional activation. 
 The hypothesis was based primarily on two previous studies: one that identified 
genes with altered expression in the absence of RA signaling (Griebel & Sandell, 
unpublished) and another that found the vasculature’s role in developing mouse salivary 
glands to include instructing epithelial patterning (Kwon, Nelson, DeSantis, Morrissey, & 
Larsen, 2017). The latter study provided reason to investigate whether RA signaling 
influences angiogenesis as a possible explanation for the defective epithelial branching 
observed in Rdh10 mutants (Wright et al, 2015). 
 This study hypothesized that immunocytochemistry in mutants who have lost the 
ability to transcribe Rdh10, the enzyme responsible for converting Vitamin A to its 
metabolically active form, would show defects in vasculature relative to control due to 
dysregulation of genes critical to angiogenesis. However, cross sectional analysis using 
CD31 primary antibodies showed no significant change in blood vessel development in 
mutants compared to controls (Fig. 4). Regardless, this experiment verified that mutants 
maintain the ability to form endothelial tissue. The imaging appeared to show more 
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vasculature associated with mesenchyme tissue in the mutants, as the vessels appear to 
cluster with a higher degree of organization around the epithelial tissue in the controls; 
however, this observation could result from lack of epithelial development in Rdh10 
knockdowns. 
 Because cross sectional analysis observes tissue in only two dimensions, an 
additional experiment examining the whole organ in three dimensions was conducted 
(Fig. 5). Melissa Metzler conducted the experiment due to time constraints placed on the 
original researcher. The results indicated an inability of the mutant to form large blood 
vessels; indeed, the mutant appears only capable of forming small, less organized 
endothelium. Additionally, nerve development was severely impaired in the mutant as 
indicated by TUBB3+ cells. These results indicate that protein products of genes targeted 
by RA signaling are necessary to form continuous blood vessels in a developing salivary 
gland. Between E11.5 and E12.5, healthy salivary glands develop discontinuous vascular 
networks within the mesenchyme surrounding the primary epithelial bud (Kwon, Nelson, 
DeSantis, Morrissey, & Larsen, 2017). At E13.5, elongated vascular networks distinct 
from TUBB3+ innervation have formed (Kwon, Nelson, DeSantis, Morrissey, & Larsen, 
2017). It is likely then that lack of protein products of genes targeted by RA signaling 
impairs elongated vascular network development between E12.5 and 13.5 either by 
damaging construction mechanisms or maintenance processes. 
To further understand how RA signaling influences vasculogenesis, we then 
chose to characterize the activity of a candidate gene within a salivary gland that is 
known both to be regulated by RA signaling and to facilitate SMG angiogenesis. One 
gene reported to have these qualities in vitro is Ctgf (Griebel & Sandell, unpublished). 
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This study used Ctgf to serve as a model for RA’s influence on vasculogenesis by 
characterizing its transcript and protein product location in a developing SMG, and 
quantify its expression in vivo. 
 RNAscope visualized Ctgf transcript location (Fig. 6) and found that Ctgf mRNA 
is almost exclusively located in budding salivary gland epithelium, not the mesenchyme. 
Canonical RA signaling influences epithelium morphogenesis by direct action 
specifically in the epithelial tissue (Abashev, 2017), which could explain why Ctgf 
transcripts are largely found in epithelial tissue. Cells secrete CTGF into extracellular 
space to mediate cell adhesion in endothelium (Ponticos, 2013), implying that although 
Ctgf transcripts lie within the epithelium their protein product may not. Additionally, the 
transcripts appear to localize around the basal lining of the epithelium and form an arch at 
the base of each endbud’s connection to the epithelial duct. These connection points are 
surrounded by salivary clefts, which are depressions in the basement membrane that 
subdivide the buds and subsequently define the boundary between the terminal proacinar 
structure and the emerging secondary ducts. The reason for the increased concentration of 
Ctgf transcript in the clefts is not known; however, CD31 staining in an E13.5 salivary 
gland shows a high degree of association between the epithelium and vasculature inside 
clefts (Kwon, Nelson, DeSantis, Morrissey, & Larsen, 2017).  Perhaps cleft-enriched Ctgf 
promotes local angiogenesis, giving rise to the numerous blood vessels characteristic of a 
healthy salivary gland.  
Endothelial genes are known to have increased expression at or near these clefts. 
Quantitative analysis of the epithelial morphology in salivary gland explants treated with 
an inhibitor for one such endothelial gene, Vegfr2, shows reduced branching 
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morphogenesis (Kwon, Nelson, DeSantis, Morrissey, & Larsen, 2017). This gene 
encodes the Vascular Endothelial Growth Factor Receptor 2; however, the genes 
encoding Vascular Endothelial Growth Factors, Vegfa, Vegfb, and Vegfc did not show 
any significant altered expression in the qPCR array data (Supplement to Fig. 11). Thus, 
although RA signaling is required for proper expression of some genes critical to salivary 
gland angiogenesis (Fig. 11), it does not regulate all genes critical to angiogenesis.  
 While the Ctgf transcripts formed an arched pattern inside the epithelium, the 
protein product localized in a rod-like shape near the connection between end and 
primary epithelial buds (Fig 7). CTGF promotes proliferation and differentiation of 
chondrocytes, and mediates heparin and divalent cation-dependent cell adhesion of 
fibroblasts, myofibroblasts, and endothelial cells (Ponticos, 2013). Thus, this geometrical 
concentration of CTGF suggests the protein is localizing to aid in the growth of the 
epithelial or endothelial structure of the gland. The protein appears to localize to 
parasympathetic nerve cells, which commonly form near endbud connections to duct 
during SMG biogenesis and are present as early as E13 (Holmberg, 2014). Its 
concentration is scarce within the mesenchyme, and most mesenchymal fluorescence can 
be attributed to autofluorescence.  
 To conclude the characterization of Ctgf, the gene’s expression in Rdh10 
knockdown mutants was compared to control expression. As previously mentioned, in 
vitro impairment of RA signaling identified multiple genes with significantly altered 
expression. However, this RA block was achieved using reverse-agonist BMS493, a non-
selective inhibitor of all three retinoic acid receptor (RAR) isoforms. Therefore, RA 
signaling in SMG cultured with BMS is less than in Rdh10 conditional knockouts, which 
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maintain approximately 30% of RA signaling. This technique required the salivary gland 
to be isolated from the organism and cultured separately, a process that could have 
impaired unknown cellular mechanisms other than RA signaling and resulted in the 
observed phenotype. In order to provide supporting data that RA signaling regulates the 
genes identified in the BMS culture, we used a conditional knockdown for Rdh10 that 
allowed the salivary gland to remain intact with the organism until the mRNA extraction. 
Compared to the use of a chemical inhibitor, the results from our experiment present data 
more closely associated with what happens to the whole organism in an absence of RA 
signaling.  
 Data from the Angiogenesis Profiler Plate reported no significant difference in 
Ctgf expression (a P value of 0.498) in Rdh10 conditional knockdowns relative to control, 
thus indicating that Ctgf is unchanged in the embryo of an Rdh10 mutant. Therefore, in 
vitro analysis shows significant expression reduction in the absence of RA signaling 
while in vivo analysis does not. Perhaps when the organ has the surrounding tissue to 
support its development it is able to compensate for lack of RA signaling with some 
unknown mechanism. Pan-RAR inhibitors eliminate the possibility for RA signaling, 
while Rdh10 conditional knockouts still allow alternative sources of RA to coactivate the 
RAR-RXR complex, such as carotenoids. Lack of change in an Rdh10 mutant of Ctgf 
transcript abundance does not necessarily mean the protein product is not a target of RA 
signaling; instead, this phenomenon could indicate that CTGF is such a critical protein 
for salivary gland organogenesis that the organism has evolved compensatory 
mechanisms such as the use of alternative transcriptional activators or homologues to 
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adjust for reduced RA. Regardless, CTGF necessity for salivary gland development is 
currently being explored by the Sandell Lab.  
 Because the characterization of this study’s principal candidate gene Ctgf revealed 
that there is no change in expression in Rdh10 mutants relative to control, additional 
candidate gene expression analyses were conducted on the other genes identified to be 
targets of RA signaling in cultured assays. Of these genes, many are known to facilitate 
angiogenesis; those genes enabling angiogenesis were chosen as candidates for further 
investigation into how RA signaling gives rise to the vascular phenotype of Rdh10 
mutants. These genes were grouped into two categories: those involved in extracellular 
matrix processes and those involved in the production of developmental growth factors. 
The former group includes Mmp2, Thb2, and Vtn. Extracellular matrix proteins contribute 
to blood vessel construction, and many of these genes were hypothesized to experience 
reduction in transcript abundance in Rdh10 knockouts. However, the expression rates of 
these genes remain unchanged in the mutants, and thus the vascular phenotype is not due 
to altered regulation of them.  
 Genes grouped by their involvement in the production of SMG developmental 
growth factors were similarly analyzed using qPCR to quantify their expression in mutant 
glands. These genes include Bmp4, Igf1, Fgf8, Bmp2, Fgf7, and Fgfr2b. The protein 
products of these genes have been shown to influence salivary gland epithelial 
morphogenesis during development (Lombaert, et al, 2010), while some such as 
Fibroblast Growth Factor Receptor 2, encoded by Fgfr2b, are involved in the formation 
of blood vessels (Santos-Ocampo, 1996). Although their functions varry, each gene 
fascilitates either the construction of blood vessel formation by primary action or by 
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enabling secondary mechanisms that give rise to vasculogenesis. Regardless, the 
expression rates of all genes within this category were not altered in Rdh10 mutant qPCR 
analyses, and thus the vascular phenotype associated with Rdh10 mutants is not due to 
altered regulation of these genes. 
Because our qPCR experiments did not identify a gene target for RA signaling 
involved in angiogenesis, a qPCR array comparing expression of identified endothelial 
genes in Rdh10 knockdowns compared to controls was performed to identify novel 
angiogenic genes mis-regulated in Rdh10 mutant SMG. The purpose of this experiment 
was to identify genes that experience dysregulation in the absence of RA signaling and 
consequently give rise to aberrant vasculogenesis. Analysis of the profiler plate reported 
five genes with significant reductions of transcript abundance in mutant samples: Angpt2, 
Jag1, Mapk14, Ptgs1, and S1pr1 (Fig. 11, 12). Additionally, the data from the profiler 
plate confirmed the findings of the previous qPCR analyses of genes involved in 
extracellular matrix processes and production of developmental growth factors.   
Except for S1pr1, all genes experienced a decrease in transcript abundance in 
mutants. Oddly, the gene product of Angpt2 functions as an antagonist of angiopoietin 1, 
which results in vascular remodeling disruption and in some cases endothelial cell 
apoptosis (Maisonpierre, et al, 1997), yet is downregulated in mutants. The gene product 
of Jag1 is one of five ligands for receptors in the NOTCH signaling pathway which 
influences cellular fate during development (Lindsell, Shawber, Boulter, & Weinmaster, 
1995), while the product of Mapk14 is a stress-activated kinase involved in integration of 
biochemical signals for proliferation, differentiation, and trascription regulation 
(Kyriakis, Avruch, 2001). Ptgs1 encodes cyclooxygenase, a critical enzyme in 
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prostaglandin biosynthesis (Wlodawer, Samuelsson, 1973). S1pr1 encodes sphingozine-
1-phosphate receptor 1 and aids in regulating endothelial cell cytoskeletal structure, 
migration, capillary-like network formation and vascular maturation (Lee, Thangada, 
Claffey, Ancellin, Liu, Kluk, Volpi, Sha'afi, & Hla, 1999). 
To supplement experiments being conducted in the Sandell Lab, this study also 
searched for changes in expression upon conditional elimination of Rdh10 of genes 
transcribing proteins involved in the metabolism of Vitamin A. Three genes were 
identified to experience significant changes in expression rates relative to control: 
Aldh1a1, Aldh1a2, and Cyp26a1. With the exception of Aldh1a2, loss of RA signaling 
resulted in reduced transcript abundance. RA is often eliminated by action of CYP26 
family enzymes (Metzler & Sandell, 2016), and in the absence of RA the cell appears to 
downregulate the protein’s production. Oxidation of all-trans-retinal (RAL) to RA, the 
third step in Vitamin A metabolism, is mediated by the ALDH1A family of enzymes, 
which includes Aldh1a1, Aldh1a2, and Aldh1a3 (Metzler & Sandell, 2016). The 
ALDH1A1 enzyme is predominantly found in salivary gland epithelium, and thus its 
reduced transcript abundance in Rdh10 knockdowns may contribute to the known 
epithelial branching defects observed in RA deficient mice.  The ALDHIA2 enzyme is 
predominantly found in salivary gland mesenchyme where development in Rdh10 
knockdowns is not typically impaired, and thus its increased trasncript abundance in such 
mutants likely results from the organism compensating for loss of RDH10.  
A total of 18 genes were tested during the scope of this study, and the data 
analysis of their Ct values can be found in the supplemental figures 
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CONCLUSION 
Knowledge presented in this study regarding how RA signaling influences 
development of salivary gland vasculature will inform potential therapies for regeneration 
of damaged salivary glands. Further studies should characterize the angiogenic gene 
targets of RA signaling identified in this study in respect to the developing salivary gland, 
which include: Angpt2, Jag1, Mapk14, Ptgs1, S1pr, and Fgfr2b. 
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Supplement to Figure 10. 
Sample Mmp2 Gapdh deltaCT Average deltadeltaCT2^(-deltadeltaCT)Average stdev SEM
Het42 25.8604 20.63793 5.222467 0.838944 0.559052
Het58 24.05577 19.8375 4.218267 -0.16526 1.121365
Het95 24.57703 20.8672 3.709833 4.383522 -0.67369 1.595146 1.091855 0.518677 0.299458
Mut42 24.4606 20.6348 3.8258 -0.55772 1.471943
Mut58 24.38587 19.56327 4.8226 0.439078 0.737606
Mut95 24.37743 20.0133 4.364133 -0.01939 1.01353 1.07436 0.370929 0.262286
Sample Thbs2 Gapdh deltaCT Average deltadeltaCT2^(-deltadeltaCT)Average stdev SEM
Het42 26.494 20.63793 5.856067 -0.35888 1.282433
Het58 27.06455 19.8375 7.22705 1.0121 0.495824
Het95 26.42893 20.8672 5.561733 6.21495 -0.65322 1.572671 1.116976 0.557164 0.321679
Mut42 26.48867 20.6348 5.853867 -0.36108 1.28439
Mut58 25.8131 19.56327 6.249833 0.034883 0.976111
Mut95 26.0604 20.0133 6.0471 -0.16785 1.123383 1.127961 0.154191 0.109029
Sample Vtn Gapdh deltaCT Average deltadeltaCT2^(-deltadeltaCT)Average stdev SEM
Het42 28.57265 20.04605 8.5266 0.298767 0.812947
Het58 27.46713 19.13675 8.330383 0.10255 0.931385
Het95 28.24317 20.41665 7.826517 8.227833 -0.40132 1.320713 1.021682 0.265653 0.153375
Mut42 28.59347 20.32835 8.265117 0.037283 0.974488
Mut58 27.7303 19.56327 8.167033 -0.0608 1.043044
Mut95 26.961 20.0133 6.9477 -1.28013 2.428614 1.482049 0.820466 0.580157
Samples Bmp4 Gapdh Ct ValuesDelta CT Control AverageDelta Delta CT 2^-(deltadeltct) Average stdev SEM
Het 42 27.9277 21.16627 6.761433 -0.4298 1.347046824
Het 58 26.81907 19.48497 7.3341 0.142866667 0.905717685
Het 95 27.85537 20.3772 7.478167 7.191233 0.286933333 0.819642482 1.024136 0.282942 0.591285
Mut 42 27.15063 20.63083 6.5198 6.977711 -0.671433333 1.592654501
Mut 58 26.87933 19.5038 7.375533 0.1843 0.880075988
Mut 95 26.6508 19.613 7.0378 -0.153433333 1.112213176 1.194981 0.363428 0.689923
Samples Igf1 Gapdh Ct ValuesDelta CT Control AverageDelta Delta CT2^-(deltadeltct)Average stdev SEM
Het 42 24.4631 21.16627 3.296833 -0.28303 1.21675
Het 58 23.5028 19.48497 4.017833 0.437967 0.738174
Het 95 23.80213 20.3772 3.424933 3.579867 -0.15493 1.11337 1.022765 0.251825 0.590494
Mut 42 23.80963 20.63083 3.1788 3.454533 -0.40107 1.320484
Mut 58 23.20157 19.5038 3.697767 0.1179 0.921528
Mut 95 23.10003 19.613 3.487033 -0.09283 1.066463 1.102825 0.201948 0.636716
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Supplement to Figure 10. Highlighted samples represent outliers referenced in Results 
section under Figure 10. 
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Supplement to Figure 13. 
Samples Fgf8 Gapdh Ct ValuesDelta CT Control AverageDelta Delta CT2^-(deltadeltct)Average stdev SEM
Het 42 33.3284 21.16627 12.16213 -1.42337 2.682107
Het 58 33.61293 19.48497 14.12797 0.542467 0.686596
Het 95 34.8436 20.3772 14.4664 13.5855 0.8809 0.543029 1.30391 1.19571 0.752813
Mut 42 32.38767 20.63083 11.75683 14.06239 -1.82867 3.552086
Mut 58 35.09817 19.5038 15.59437 2.008867 0.248468
Mut 95 34.44897 19.613 14.83597 1.250467 0.420312 1.406956 1.859724 0.812306
Sample Bmp2 CT Gapdh deltaCT Avg deltaCT Het deltadeltaCT2 (̂-deltadeltaCT) Average stdev SEM
Het 42 29.6241 20.73097 8.893133 -0.1798 1.132726845
Het 58 28.64493 19.41947 9.225467 0.152533 0.89966928
Het 95 29.30747 20.20727 9.1002 9.072933333 0.027267 0.981277668 1.004558 0.11826 0.068277
Mut 42 29.57503 20.86393 8.7111 -0.36183 1.285057873
Mut 58 29.37843 19.76767 9.610767 0.537833 0.688804592
Mut 95 28.6584 19.5254 9.133 0.060067 0.959219793 0.977694 0.298556 0.172371
Sample Fgf7 CT Gapdh deltaCT Avg deltaCT Hetdel adeltaCT2^(-deltadeltaCT)Average stdev SEM
Het 42 27.93657 20.73097 7.2056 0.267656 0.830668
Het 58 26.43253 19.41947 7.013067 0.075122 0.949262
Het 95 26.80243 20.20727 6.595167 6.937944 -0.34278 1.268196 1.016042 0.226279 0.130642
Mut 42 27.26763 20.86393 6.4037 -0.53424 1.448184
Mut 58 26.42817 19.76767 6.6605 -0.27744 1.212046
Mut 95 26.98397 19.5254 7.458567 0.520622 0.697071 1.1191 0.384085 0.221752
Sample Fgfr2b CT Gapdh deltaCT Avg deltaCT Hetdel adeltaCT2^(-deltadeltaCT)Average stdev SEM
Het 42 26.39213 20.73097 5.661167 -0.3692 1.291636
Het 58 25.72023 19.41947 6.300767 0.2704 0.82909
Het 95 26.33643 20.20727 6.129167 6.030367 0.0988 0.933809 1.018178 0.242541 0.140031
Mut 42 27.3854 20.86393 6.521467 0.4911 0.711482
Mut 58 25.96617 19.76767 6.1985 0.168133 0.889993
Mut 95 26.5885 19.5254 7.0631 1.032733 0.488783 0.696753 0.20101 0.116053
sample Aldh1a1 Gapdh deltaCT average deltadeltaCT 2 (̂-deltadeltaCT) Average stdev SEM
Het 42 28.98723 20.67987 8.307367 0.674166667 0.626694107
Het 95 28.32067 21.2048 7.115867 -0.517333333 1.431307184
Het 58 27.81097 20.3346 7.476367 7.6332 -0.156833333 1.11483742 1.057613 0.405347 0.234027
Mut 42 30.75967 20.68363 10.07603 2.442833333 0.18392209
Mut 95 30.1823 20.17447 10.00783 2.374633333 0.192825354
Mut 58 29.15733 20.571 8.586333 9.556733 0.953133333 0.516509456 0.297752 0.189502 0.109409
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sample Aldh1a2 Gapdh deltaCT average deltadeltaCT 2 (̂-deltadeltaCT) Average stdev SEM
Het 42 24.79417 20.67987 4.1143 0.565388889 0.675773232
Het 95 24.4856 21.2048 3.2808 -0.268111111 1.204230123
Het 58 23.58623 20.3346 3.251633 3.548911 -0.297277778 1.228823556 1.036276 0.312446 0.180391
Mut 42 23.6748 20.68363 2.991167 -0.557744444 1.471966099
Mut 95 22.8522 20.17447 2.677733 -0.871177778 1.829155565
Mut 58 23.40377 20.571 2.832767 -0.716144444 1.642785871 1.647969 0.178651 0.103144
sample Aldh1a3 Gapdh deltaCT average deltadeltaCT2^(-deltadeltaCT)Average stdev SEM
Het 42 28.15847 20.67987 7.4786 0.340167 0.78995
Het 95 28.30107 21.2048 7.096267 -0.04217 1.029659
Het 58 27.17503 20.3346 6.840433 7.138433 -0.298 1.229439 1.016349 0.220047 0.127044
Mut 42 27.76307 20.68363 7.079433 -0.059 1.041743
Mut 95 27.04573 20.17447 6.871267 -0.26717 1.203442
Mut 58 27.21833 20.571 6.647333 6.866011 -0.4911 1.405516 1.216901 0.182259 0.105228
Sample Cyp26a1 Gapdh deltaCT average deltadeltaCT 2 (̂-deltadeltaCT) Average stdev SEM
Het 42 29.4387 21.20327 8.235433 0.295666667 0.814695776
Het 58 28.91903 20.68047 8.238567 0.2988 0.81292829
Het 95 28.65933 21.31403 7.3453 7.939767 -0.594466667 1.5099143 1.045846 0.401896 0.232035
Mut 42 30.14207 21.3645 8.777567 0.8378 0.559496108
Mut 58 30.1764 21.209 8.9674 1.027633333 0.490514152
Mut 95 32.0311 20.609 11.4221 3.482333333 0.08947737 0.379829 0.253807 0.146535
Sample Cyp26b1 Gapdh deltaCT average deltadeltaCT2^(-deltadeltaCT) average stdev SEM
Het 42 27.78403 21.20327 6.580767 0.357978 0.780257499
Het 58 26.47547 20.68047 5.795 -0.42779 1.345170354
Het 95 27.60663 21.31403 6.2926 6.222789 0.069811 0.952762733 1.026064 0.289502 0.167144
Mut 42 28.02393 21.3645 6.659433 0.436644 0.738851101
Mut 58 27.4279 21.209 6.2189 -0.00389 1.002699209
Mut 95 27.64497 20.609 7.035967 0.813178 0.569126879 0.770226 0.218482 0.126141
Sample Dhrs3 Gapdh deltaCT average deltadeltaCT2^(-deltadeltaCT)average stdev SEM
Het 42 28.94647 21.20327 7.7432 1.015989 0.494489
Het 58 27.19197 20.68047 6.5115 -0.21571 1.161276
Het 95 27.24097 21.31403 5.926933 6.727211 -0.80028 1.741436 1.132401 0.623975 0.360252
Mut 42 28.7269 21.3645 7.3624 0.635189 0.643857
Mut 58 27.54003 21.209 6.331033 -0.39618 1.316017
Mut 95 27.84337 20.609 7.234367 0.507156 0.703608 0.887827 0.372025 0.214788
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sample RARb gapdh deltaCT average deltadeltaCT2^(-deltadeltaCT)Average stdev SEM
Het 42 25.2227 20.39855 4.82415 0.8703 0.547033
Het 95 24.51433 21.40297 3.111367 -0.84248 1.793134
Het 58 24.2335 20.30747 3.926033 3.95385 -0.02782 1.019468 1.119878 0.629089 0.363205
Mut 42 24.46797 20.76727 3.7007 -0.25315 1.191806
Mut 95 24.06757 20.49805 3.569517 -0.38433 1.305256
Mut 58 24.42217 21.1346 3.287567 -0.66628 1.586979 1.361347 0.20347 0.117473
sample stra6 gapdh deltaCT average deltadeltaCT 2^(-deltadeltaCT) Average stdev SEM
Het 42 24.59493 20.39855 4.196383 0.7414 0.598158614
Het 95 24.45653 21.40297 3.053567 -0.401416667 1.320804249
Het 58 23.42247 20.30747 3.115 3.454983 -0.339983333 1.265741971 1.061568 0.402268 0.232249
Mut 42 24.80363 20.76727 4.036367 0.581383333 0.668322646
Mut 95 23.75133 20.49805 3.253283 -0.2017 1.150052722
Mut 58 23.7241 21.1346 2.5895 -0.865483333 1.821949957 1.213442 0.57942 0.334528
Ct.B1275.H1 Ct.B1275.H2 Ct.B1299.H1 Ct.B1275.M1 Ct.B1275.M2 Ct.B1299.M1
S1pr1 0.0249 -0.0295 0.0046 -0.4925 -0.5125 -0.6327
Angpt2 0.00796667 0.20416667 -0.21213333 1.217866667 0.968266667 0.997366667
Jag1 0.1432 -0.0124 -0.1308 0.4718 0.2892 0.4119
Ptgs1 0.3526 0.0077 -0.3603 0.6339 0.9218 0.7807
Mapk14 -0.0716 0.0794 -0.0078 0.1655 0.1115 0.2594
Ct.B1275.H1 Ct.B1275.H2 Ct.B1299.H1 Ct.B1275.M1 Ct.B1275.M2 Ct.B1299.M1
S1pr1 0.98288872 1.02065833 0.9968166 1.406880703 1.426520026 1.550463969
Angpt2 0.99449315 0.86803994 1.15839986 0.429917974 0.511119782 0.500913477
Jag1 0.90550844 1.00863207 1.09490067 0.72106439 0.818355726 0.751632836
Ptgs1 0.78317141 0.99467698 1.28369281 0.644431982 0.527850029 0.582084296
Mapk14 1.0508815 0.94645118 1.00542119 0.891619454 0.92562517 0.835435295
Avg. Het stdev Het Avg. mut stdev mut
S1pr1 1.00012122 0.01910042 1.46128823 0.077850239
Angpt2 1.00697765 0.145582 0.48065041 0.044230954
Jag1 1.00301373 0.09482103 0.76368432 0.049752685
Ptgs1 1.02051373 0.25125897 0.58478877 0.058338011
Mapk14 1.00091796 0.0523606 0.88422664 0.045547159
DeltaDelta CT values
Fold Change (2^-deltadeltaCT)
STATS
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Supplement to Figure 12. Boxplots of sample medians normalized to Gapdh. 
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Ct.B1275.H1 Ct.B1275.H2 Ct.B1299.H1 Ct.B1275.M1 Ct.B1275.M2 Ct.B1299.M1 p.value t.statistic log2 foldchange
S1pr1 5.9914 5.937 5.9711 5.474 5.454 5.3338 0.000303 11.72205 0.5459
Angpt2 8.5574 8.7536 8.3373 9.7673 9.5177 9.5468 0.001796 -7.38145 -1.06117
Jag1 5.6459 5.4903 5.3719 5.9745 5.7919 5.9146 0.0151 -4.07991 -0.39097
Ptgs1 9.3267 8.9818 8.6138 9.608 9.8959 9.7548 0.024707 -3.50842 -0.7788
Mapk14 5.3609 5.5119 5.4247 5.598 5.544 5.6919 0.043798 -2.90727 -0.1788
Tnf 10.5096 10.8826 10.7022 12.0226 11.0812 11.3587 0.057755 -2.63711 -0.78937
Tgfa 10.6865 10.6077 9.5347 11.8848 11.0573 11.2672 0.065249 -2.52155 -1.1268
Nos3 8.0971 8.2776 8.2284 8.1366 7.937 7.9183 0.082085 2.309415 0.203733
Edn1 10.3318 9.7457 9.1095 10.7922 10.2616 11.1957 0.083332 -2.29571 -1.02083
Anpep 6.3818 6.3047 5.9777 6.9556 6.3321 6.8469 0.098777 -2.1428 -0.49013
F3 8.7465 8.9911 8.2054 9.0831 9.4659 9.0694 0.103738 -2.09928 -0.55847
Sphk1 8.4988 8.7148 7.6797 9.1381 8.7825 9.0174 0.109404 -2.0523 -0.68157
Pdgfa 3.812 4.0683 3.4761 4.1077 4.1224 4.6537 0.10964 -2.0504 -0.50913
B2m 4.298 4.0155 4.1422 4.0705 3.9092 3.7949 0.117955 1.986253 0.227033
Tgfb1 6.7671 6.655 6.1756 6.9016 6.9231 6.8377 0.12477 -1.93726 -0.3549
Igf1 3.3456 2.8091 2.5906 2.5145 2.5036 2.4407 0.129955 1.90189 0.428833
Tgbfb2 5.1353 4.4285 4.4652 4.3433 4.1547 4.2165 0.137356 1.853971 0.438167
Fgfr3 10.2621 10.8544 10.6917 10.7158 11.2173 11.1742 0.143816 -1.81436 -0.43303
Gusb 6.821 6.7937 6.2921 6.9493 6.8407 7.1755 0.149601 -1.78048 -0.3529
Fgf2 8.2062 7.7506 7.778 7.7848 7.5112 7.5493 0.157076 1.738701 0.2965
Mmp2 5.7267 5.7825 5.1058 6.0267 5.7793 5.9752 0.165674 -1.69318 -0.38873
Tgfb3 6.5014 6.3737 6.6157 6.5233 6.061 5.938 0.166926 1.686757 0.322833
Fgf1 12.0208 11.5408 10.9164 12.3586 11.636 12.5761 0.178259 -1.63084 -0.69757
Col18a1 4.5261 4.2651 4.0378 4.1337 4.0184 4.0327 0.214447 1.474171 0.214733
Cdh5 5.0916 4.6959 4.7658 4.7606 4.6571 4.564 0.22956 1.416568 0.190533
Serpine1 10.633 9.6736 10.3556 9.737 10.0376 9.5303 0.231315 1.410125 0.452433
Tbx1 8.9043 8.3223 8.2476 8.0833 8.4431 7.6519 0.234495 1.398577 0.431967
Vegfc 7.3721 6.8753 6.8531 7.2161 7.3384 7.2541 0.244704 -1.36252 -0.23603
Serpinf1 4.0474 3.8662 3.7366 3.8774 3.546 3.6986 0.251656 1.338807 0.176067
Flt1 7.7444 7.4852 7.7919 7.9605 7.6075 8.282 0.2718 -1.27354 -0.27617
Epas1 5.9621 5.8413 6.1246 5.9687 5.4935 5.8405 0.272546 1.271212 0.208433
Nrp1 5.1421 4.8934 4.5702 5.2367 5.0494 5.0023 0.275636 -1.26164 -0.22757
Hgf 9.217 9.5879 8.5687 9.584 9.4785 9.4267 0.284821 -1.23379 -0.37187
Plau 7.0625 6.5093 6.1708 7.2989 6.7738 6.806 0.289603 -1.21962 -0.3787
Tnfsf12 6.2326 5.7746 6.0184 6.0614 5.6951 5.7369 0.370014 1.009096 0.1774
Tek 7.6615 6.758 7.1337 7.2649 7.5826 7.5474 0.374067 -0.99961 -0.28057
Itgav 5.5047 5.3474 4.7217 5.4976 5.3376 5.4502 0.385675 -0.97294 -0.2372
Actb -1.3148 -1.3427 -1.278 -1.0833 -1.4036 -1.1648 0.388691 -0.96613 -0.0946
Tgfbr1 5.7858 6.0946 5.7117 6.2295 6.0598 5.7896 0.402975 -0.93445 -0.16227
Kdr 5.128 4.6944 4.8174 4.7223 4.5585 4.9059 0.407743 0.924082 0.151033
Timp1 8.6077 8.6407 7.6873 8.1663 7.9691 7.9373 0.420229 0.897417 0.287667
Angpt1 12.6453 12.455 11.4123 12.0792 11.2372 11.9602 0.425526 0.886303 0.412
Pecam1 5.0579 4.5897 4.7276 4.8459 4.5447 4.563 0.454167 0.828089 0.140533
Efna1 6.8831 6.4955 6.4282 6.369 6.1637 6.7478 0.473923 0.789619 0.175433
Figf 11.6198 11.8952 10.8923 10.4633 11.8855 10.8793 0.489764 0.759664 0.393067
Ctgf 9.092 9.4602 8.4747 9.5254 8.9066 9.3572 0.498445 -0.74356 -0.2541
Pgf 9.92 9.0344 8.9143 9.0488 8.8375 9.2546 0.514014 0.715195 0.2426
Akt1 3.384 3.6721 2.9399 3.679 3.4289 3.3813 0.517867 -0.70827 -0.1644
Timp2 2.7926 2.5372 2.2902 2.6639 2.2221 2.3159 0.519786 0.704841 0.139367
Vegfb 4.5152 4.2644 3.8398 4.4006 4.3727 4.2686 0.522444 -0.7001 -0.14083
Mmp9 8.2408 8.1938 8.4353 8.3766 8.0787 8.9159 0.549413 -0.65295 -0.1671
Tie1 5.8284 5.4823 5.4649 5.9536 5.5245 5.6374 0.551889 -0.64871 -0.1133
Thbs1 5.0116 4.8398 4.6568 4.9787 4.8216 4.2292 0.55822 0.637911 0.159567
Ang 12.6401 11.7404 11.4751 12.2881 11.7207 12.6692 0.573227 -0.61265 -0.27413
Ptk2 5.1112 5.2695 4.8192 5.1263 5.2104 5.1073 0.580912 -0.59988 -0.08137
Vegfa 6.0856 5.7412 5.6357 5.6021 5.568 5.9799 0.611599 0.54998 0.104167
Smad5 5.0916 4.3669 4.0855 4.4633 4.2048 4.3793 0.620785 0.535351 0.165533
Hifla 4.2017 4.252 3.9982 4.3753 3.9557 4.3522 0.648548 -0.49192 -0.0771
Itgb3 7.1216 7.2808 6.6092 6.9138 6.7497 7.0301 0.652713 0.485504 0.106
Thbs2 6.8552 6.5147 6.6464 7.2816 6.8185 6.2929 0.699201 -0.41535 -0.12557
Mmp14 2.7217 2.4824 2.4854 2.8935 2.4017 2.5589 0.756568 -0.33198 -0.05487
Erbb2 5.8192 5.6107 5.3304 5.6359 5.5214 5.4546 0.759924 0.327199 0.049467
Ephb4 3.7282 3.5706 3.254 3.592 3.3429 3.4723 0.772503 0.309346 0.048533
Efnb2 2.6451 2.4614 1.8408 2.3425 1.9693 2.396 0.788163 0.287285 0.079833
Eng 5.4893 5.3689 5.1003 5.319 5.2947 5.4416 0.806999 -0.26097 -0.03227
Bai1 10.6838 10.3338 10.6957 10.8263 10.1997 10.8683 0.818791 -0.24461 -0.06033
Nrp2 2.4132 2.2796 1.9624 2.3626 2.0414 2.3761 0.821385 -0.24103 -0.04163
Lect1 9.8835 10.315 10.4565 10.2094 9.4898 10.7173 0.850537 0.200957 0.0795
Egf 11.56 12.2785 12.2349 11.979 12.223 12.0144 0.855055 -0.19478 -0.04767
Fn1 2.6517 2.2381 1.7721 2.1936 2.0037 2.3124 0.859848 0.188247 0.050733
Ccl2 12.44 11.8353 13.3544 12.1919 12.9054 12.8076 0.861945 -0.18539 -0.09173
Hsp90ab1 0.2427 0.1558 -0.326 0.2566 -0.0515 -0.0348 0.880316 -0.16043 -0.0326
Fgf6 14.8196 15.5993 10.7005 13.6626 14.645 13.4116 0.904549 -0.1277 -0.19993
Ccl11 6.3574 6.3099 5.9081 6.8873 5.7356 6.0812 0.913231 -0.11602 -0.0429
Cxcl5 12.9484 14.2246 12.8411 12.1015 13.7697 14.4168 0.916754 -0.11128 -0.0913
Mmp19 10.2143 11.3131 10.7995 10.5197 10.8557 11.0682 0.918095 -0.10948 -0.0389
Mdk 0.7837 0.7421 0.4843 0.792 0.5021 0.6935 0.955579 0.059271 0.0075
Gapdh 0 0 0 0 0 0 NA NA 0
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Supplement to Figure 12. Ct values, P values, t statistics, and log2 fold-change for genes 
examined in the Angiogenesis Profiler Plate. Highlighted P values indicate genes with 
statistically significant expression changes. 
 
Primer Efficiencies 
 
 Primer Efficiency Figure 1. Assay efficiencies of the displayed primers were 
compared over a wide and narrow dynamic range of cDNA concentrations. Efficiencies 
were calculated using one-fifth dilution series. Initial primers for Bmp2 and Fgf2 
displayed unacceptable efficiencies; alternative primers for those genes were then tested.  
Primer Efficiency Slope
Bmp2 110.43% -3.095
Bmp2 #2 101.05% -3.2974
Bmp4 105.35% -3.2
Fgf8 109.78% -3.1079
Fgf2 84.35% -3.7643
Fgf2 #2 106.90% -3.1677
Igf1 101.44% -3.2879
 51   
 
Primer Efficiency Figure 2. Analysis of primer efficiency.  
Standard curves were generated by qPCR using a 5-fold serial dilution of 
heteroplasmic DNA (relative concentration of 1, .2, .04, .008 ng per reaction). First 
degree linear regressions were fitted for the log of input amount of template versus the 
Ct.  
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